Summarising censored survival data using the mean residual life function

Stat Med. 2015 May 20;34(11):1965-76. doi: 10.1002/sim.6431. Epub 2015 Jan 28.

Abstract

The mean residual life function provides a clear and simple summary of the effect of a treatment or a risk factor in units of time, avoiding hazard ratios or probability scales, which require careful interpretation. Estimation of the mean residual life is complicated by the upper tail of the survival distribution not being observed as, for example, patients may still be alive at the end of the follow-up period. Various approaches have been developed to estimate the mean residual life in the presence of such right censoring. In this work, a novel semi-parametric method that combines existing non-parametric methods and an extreme value tail model is presented, where the limited sample information in the tail (prior to study termination) is used to estimate the upper tail behaviour. This approach will be demonstrated with simulated and real-life examples.

Keywords: extreme value theory; generalised Pareto distribution; mean residual life; survival analysis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Breast Neoplasms / epidemiology*
  • Computer Simulation
  • Double-Blind Method
  • Female
  • Humans
  • Ireland / epidemiology
  • Kaplan-Meier Estimate
  • Leukemia / therapy*
  • Male
  • Neoplasm Recurrence, Local / epidemiology*
  • Prognosis
  • Randomized Controlled Trials as Topic
  • Receptor, ErbB-2 / analysis
  • Risk Factors
  • Statistics, Nonparametric
  • Survival Analysis*
  • Time Factors

Substances

  • Receptor, ErbB-2